Literature DB >> 23257320

The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology.

Lawrence J Laslett1, Peter Alagona, Bernard A Clark, Joseph P Drozda, Frances Saldivar, Sean R Wilson, Chris Poe, Menolly Hart.   

Abstract

The environment in which the field of cardiology finds itself has been rapidly changing. This supplement, an expansion of a report created for the Board of Trustees, is intended to provide a timely snapshot of the socio-economic, political, and scientific aspects of this environment as it applies to practice both in the United States and internationally. This publication should assist healthcare professionals looking for the most recent statistics on cardiovascular disease and the risk factors that contribute to it, drug and device trends affecting the industry, and how the practice of cardiology is changing in the United States.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257320     DOI: 10.1016/j.jacc.2012.11.002

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  225 in total

Review 1.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

2.  Beyond BMI: The Next Chapter in Childhood Obesity Management.

Authors:  Tracey L Bridger; Anne Wareham
Journal:  Curr Obes Rep       Date:  2014-09

3.  Resveratrol attenuated estrogen-deficient-induced cardiac dysfunction: role of AMPK, SIRT1, and mitochondrial function.

Authors:  Zijun Meng; Hongjiang Jing; Lu Gan; Hua Li; Bingde Luo
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

4.  Myocardial infarction risk among patients with fractures receiving bisphosphonates.

Authors:  Cory B Pittman; Lisa A Davis; Angelique L Zeringue; Liron Caplan; Kent R Wehmeier; Jeffrey F Scherrer; Hong Xian; Francesca E Cunningham; Jay R McDonald; Alexis Arnold; Seth A Eisen
Journal:  Mayo Clin Proc       Date:  2014-01       Impact factor: 7.616

5.  Mapping eQTLs in the Norfolk Island genetic isolate identifies candidate genes for CVD risk traits.

Authors:  Miles C Benton; Rod A Lea; Donia Macartney-Coxson; Melanie A Carless; Harald H Göring; Claire Bellis; Michelle Hanna; David Eccles; Geoffrey K Chambers; Joanne E Curran; Jacquie L Harper; John Blangero; Lyn R Griffiths
Journal:  Am J Hum Genet       Date:  2013-12-05       Impact factor: 11.025

6.  The unmet need for philanthropic funding of early career cardiovascular investigators.

Authors:  Tariq Ahmad; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

Review 7.  Management of refractory cardiogenic shock.

Authors:  Alex Reyentovich; Maya H Barghash; Judith S Hochman
Journal:  Nat Rev Cardiol       Date:  2016-06-30       Impact factor: 32.419

8.  Management of severe pulmonary hypertension in patients undergoing mitral valve surgery.

Authors:  Carlos D Davila; Paul R Forfia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

9.  Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.

Authors:  Petra G van Peet; Anton J M de Craen; Jacobijn Gussekloo; Wouter de Ruijter
Journal:  Age (Dordr)       Date:  2014-05-08

Review 10.  Neurovascular Complications of the Upper Extremity Following Cardiovascular Procedures.

Authors:  Bryan G Beutel; Scott D Lifchez; Eitan Melamed
Journal:  J Hand Microsurg       Date:  2016-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.